Navigation Links
Scientists rewrite rulebook on breast cancer in landmark global study
Date:4/18/2012

Scientists at the BC Cancer Agency and University of British Columbia have identified new breast cancer genes that could change the way the disease is diagnosed and form the basis of next-generation treatments.

Researchers have reclassified the disease into 10 completely new categories based on the genetic fingerprint of a tumour. Many of these genes could offer much-needed insight into breast cancer biology, allowing doctors to predict whether a tumour will respond to a particular treatment. Whether the tumour is likely to spread to other parts of the body or if it is likely to return following treatment.

The study, published online today in the international journal Nature*, is the largest global study of breast cancer tissue ever performed and the culmination of decades of research into the disease.

In the future, this information could be used by doctors to better tailor treatment to the individual patient.

The team at the BC Cancer Agency, in collaboration with Cancer Research UK's Cambridge Research Institute and Manitoba Institute of Cell Biology at University of Manitoba, analyzed the DNA and RNA of 2,000 tumour samples taken from women diagnosed with breast cancer between five and 10 years ago. The sheer number of tumours mapped allowed researchers to spot new patterns in the data.

Study milestones include:

  • Classified breast cancer into 10 subtypes grouped by common genetic features, which correlate with survival. This new classification could change the way drugs are tailored to treat women with breast cancer.

  • Discovered several completely new genes that had never before been linked to breast cancer. These genes that drive the disease are all targets for new drugs that may be developed. This information will be available to scientists worldwide to boost drug discovery and development.

  • Revealed the relationship between these genes and known cell signaling pathways networks that control cell growth and division. This could pinpoint how these gene faults cause cancer, by disrupting important cell processes.

This is the second major breakthrough announced by BC Cancer Agency scientists in as many weeks. On April 4, a team led by Dr. Sam Aparicio celebrated the decoding of the genetic makeup of the most-deadly of breast cancers, triple-negative breast cancer, which until then was defined by what it was missing, not what it was. Similar to that announcement, today's new discovery identifies genes that were previously unknown to be linked to breast cancer and makes it clear that breast cancer is an umbrella term for what really is a number of unique diseases.

While the research is unlikely to benefit women who currently have breast cancer, it substantially advances how scientists approach further research and clinical trials by providing them with a springboard to develop new treatment options and drugs targeted to specific genes.

The research was carried out in collaboration with the following institutes:

  • British Columbia Cancer Agency, Vancouver
  • University of British Columbia, Vancouver
  • Department of Oncology, University of Cambridge
  • Department of Applied Mathematics and Theoretical Physics, University of Cambridge
  • Department of Genetics, The Institute for Cancer Research
  • Oslo University Hospital
  • Department of Histopathology, University of Nottingham
  • Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre
  • King's College London, Breakthrough Breast Cancer Research Unit
  • Manitoba Institute of Cell Biology, University of Manitoba
  • NIHR Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London
  • Institute for Clinical Medicine, Faculty of Medicine, University of Oslo
  • Cambridge Experimental Cancer Medicine Centre.


'/>"/>

Contact: Brian Lin
brian.lin@ubc.ca
604-822-2234
University of British Columbia
Source:Eurekalert

Related medicine news :

1. Scientists tailor cell surface targeting system to hit organelle ZIP codes
2. Scientists identify major source of cells defense against oxidative stress
3. Scientists uncover multiple faces of deadly breast cancer
4. Scientists solving the mystery of human consciousness
5. A*STAR scientists discover special class of natural fats stimulates immune cells to fight diseases
6. Hutchinson Center and TGen scientists discover potential break through in pancreatic cancer
7. Scientists study link between amyloid beta peptide levels and Alzheimers disease
8. Scientists measure how energy is spent in martial arts
9. Scientists link 2 cancer-promoting pathways in esophageal cancer
10. Hutchinson Center scientists break through pancreas cancer treatment barrier
11. Sanford-Burnham scientists unravel cancer drugs secret to resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... 24, 2017 , ... Accordant Technology, a trusted IT solutions ... an analytics-first approach, layered with machine learning, that provides real-time visibility into the ... cloud to the edge. Through the new partnership, customers get the real-time situational ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... food ingredient solutions for the food and beverage industry offers Citri-Fi®, a natural ... statements during the purchasing decision process. As a result, labels need to deliver ...
(Date:5/23/2017)... ... May 23, 2017 , ... Allegheny Health Network and ... Joy D’Achille Center for Women’s Behavioral Health at West Penn Hospital , a ... for women suffering from pregnancy-related depression. Construction of the Center is underway with ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... exercise professionals, is pleased to announce the organization’s Certified Strength Coach credential has ... Certified Strength Coach (CSC) program validates the competency of qualified candidates for jobs ...
(Date:5/23/2017)... ... May 23, 2017 , ... MedTech For Solutions ... modern ART laboratory, to provide hands-on training utilizing cutting-edge equipment at its recently-opened ... a MedTech Group Purchasing vendor , will provide specialized equipment to ensure ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... , May 9, 2017  Demonstrating its commitment ... of directors for the Pharmaceutical Research and Manufacturers ... membership. Biopharmaceutical companies will now have to meet ... to be eligible to join PhRMA. ... board is sending a clear message that being ...
(Date:5/8/2017)... May 8, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., ... ("WRB"), a health care service center company based ... WRB specializes in relationship management programs for leading pharmaceutical ... WRB will join Envoy Health ... services for manufacturers, biotech firms, and other service companies. ...
(Date:5/4/2017)... MONTREAL , May 4, 2017  Fortuna Fix Inc. (" ... aiming to be the first to eliminate the need for ... autologous cells to treat neurodegenerative diseases. Fortuna ... ("SAB") with Professor Michael Fehlings , MD, PhD; Father ... Hack , MD, MPH; and Professor James Giordano , ...
Breaking Medicine Technology: